A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder
Public ClinicalTrials.gov record NCT00368030. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Depression Response to Eszopiclone in Adults With Major Depressive Disorder (DREAMDD): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 8-Week, Safety & Efficacy Study of Eszopiclone 3 mg Compared to Placebo in Subjects With Insomnia Related to MDD Acronym: DREAMDD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate subjective sleep efficacy in subjects with insomnia related to major depressive disorder.
Study identification
- NCT ID
- NCT00368030
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 545 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2004 (Type not available)
- Primary completion
- Oct 2004 (Actual)
- Completion
- Oct 2004 (Actual)
- Last update posted
- Feb 22, 2012
2004
United States locations
- U.S. sites
- 65
- U.S. states
- 30
- U.S. cities
- 65
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Peoria | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Fayetteville | Arkansas | — | — |
| Not listed | Garden Grove | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | Northridge | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Wheat Ridge | Colorado | — | — |
| Not listed | New Britian | Connecticut | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Miami Beach | Florida | — | — |
| Not listed | North Miami | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Decatur | Georgia | — | — |
| Not listed | Smyrna | Georgia | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Rockville | Maryland | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Braintree | Massachusetts | — | — |
| Not listed | Brighton | Massachusetts | — | — |
| Not listed | Brockton | Massachusetts | — | — |
| Not listed | Cambridge | Massachusetts | — | — |
| Not listed | Watertown | Massachusetts | — | — |
| Not listed | Farmington Hills | Michigan | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Clementon | New Jersey | — | — |
| Not listed | Morestown | New Jersey | — | — |
| Not listed | Lawerence | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | The Bronx | New York | — | — |
| Not listed | Durham | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Bismarck | North Dakota | — | — |
| Not listed | Beachwood | Ohio | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Eugene | Oregon | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Salem | Oregon | — | — |
| Not listed | Springfield | Oregon | — | — |
| Not listed | Conshohocken | Pennsylvania | — | — |
| Not listed | Emmaus | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Scotland | Pennsylvania | — | — |
| Not listed | Anderson | South Carolina | — | — |
| Not listed | Madison | Tennessee | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Selmer | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Wichita Falls | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Lakewood | Washington | — | — |
| Not listed | Seatle | Washington | — | — |
| Not listed | Spokane | Washington | — | — |
| Not listed | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00368030, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2012 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00368030 live on ClinicalTrials.gov.